Myrexis Q2 FY13: net loss $4.8M

Key figures from this report

These are the numbers Myrexis reported for Q2 FY13, the quarter ended Dec 31, 2012, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

1. Net income−$4.8MAgainst −$7.5M in Q2 FY1210-Q income statement, on EDGAR
2. Cash and cash equivalents$44.4M+174% from $16.2M in Q2 FY12Cash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
3. Cash from operations−$5.5MAgainst −$6.5M in Q2 FY1210-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters